Nutex HealthNUTX.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Nutex Health (NUTX.O) trades at a P/E of 7.08x, P/B of 3.24x, P/S of 1.51x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 30th percentile over the trailing 10Y window (vs. 30th percentile over 3Y); P/B sits at the 52nd percentile over the trailing 10Y window (vs. 58th percentile over 3Y); P/S sits at the 70th percentile over the trailing 10Y window (vs. 94th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 9th percentile within its industry and the 10th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.39%, ranking at the 87th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 22.1 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. Nutex Health operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: NUTX · NUTX
Want the full picture on whether Nutex Health (NUTX.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 7.08 | ||||||
| P/B (MRQ) | 3.24 | ||||||
| P/S (TTM) | 1.51 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.39% |